Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Hydrochlorothiazide Valsartan products are in shortage in Canada (5 of 27 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 31, 2026.
A combination of a blood pressure medication and a diuretic used to lower blood pressure.
Products affected
5 / 27
In shortage since
Aug 26, 2024
Est. full return
Jul 31, 2026
Reports on file
54
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
AURO-VALSARTAN HCT
12.5MG
160MG · TABLET · AURO PHARMA INC
DIN 02408120 · since Dec 5, 2024, est. end Jul 31, 2026 · Demand increase for the drug.
Active shortage
AURO-VALSARTAN HCT
25MG
320MG · TABLET · AURO PHARMA INC
DIN 02408155 · since Aug 26, 2024, no end estimate · Demand increase for the drug.
Active shortage
AURO-VALSARTAN HCT
12.5MG
320MG · TABLET · AURO PHARMA INC
DIN 02408147 · since Aug 26, 2024, no end estimate · Demand increase for the drug.
Active shortage
AURO-VALSARTAN HCT
12.5MG
80MG · TABLET · AURO PHARMA INC
DIN 02408112 · since Aug 26, 2024, no end estimate · Demand increase for the drug.
Active shortage
AURO-VALSARTAN HCT
25MG
160MG · TABLET · AURO PHARMA INC
DIN 02408139 · since Aug 26, 2024, no end estimate · Demand increase for the drug.
Resolved
SANDOZ VALSARTAN HCT
25MG
320MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02356732 · ended Sep 15, 2025 · Disruption of the manufacture of the drug.
Discontinued
TEVA-VALSARTAN/HCTZ
25MG
320MG · TABLET · TEVA CANADA LIMITED
DIN 02357046
Discontinued
TEVA-VALSARTAN/HCTZ
12.5MG
320MG · TABLET · TEVA CANADA LIMITED
DIN 02357038
Resolved
TEVA-VALSARTAN/HCTZ
12.5MG
320MG · TABLET · TEVA CANADA LIMITED
DIN 02357038 · ended Apr 7, 2025 · Disruption of the manufacture of the drug.
Discontinued
TEVA-VALSARTAN/HCTZ
25MG
160MG · TABLET · TEVA CANADA LIMITED
DIN 02357011
Discontinued
TEVA-VALSARTAN/HCTZ
12.5MG
160MG · TABLET · TEVA CANADA LIMITED
DIN 02357003
Discontinued
TEVA-VALSARTAN/HCTZ
12.5MG
80MG · TABLET · TEVA CANADA LIMITED
DIN 02356996
Showing 12 of 54 reports. All reports are on file with Health Canada.
What's happening
Hydrochlorothiazide Valsartan is currently affected by 5 active shortage reports filed with Health Canada by AURO PHARMA INC.
The reported cause is: demand increase for the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Hydrochlorothiazide Valsartan is classified under “ANGIOTENSIN II ANTAGONISTS, COMBINATIONS” (ATC C09DA).
Recent changes
No changes recorded yet.
Common questions
What is Hydrochlorothiazide Valsartan used for?
A combination of a blood pressure medication and a diuretic used to lower blood pressure.
When will Hydrochlorothiazide Valsartan be back in stock in Canada?
The latest manufacturer estimate is Jul 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Hydrochlorothiazide Valsartan in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.